PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Hanjia Design Group
300746
4
SPEEDBIRD
831768
5
GUANGZIINTERNATIONAL
836892
CN Stock MarketDetailed Quotes
688073 Bide Pharmatech
- 41.39
- -0.30-0.72%
Trading Apr 25 10:16 CST
3.76BMarket Cap30.82P/E (TTM)
42.49High41.30Low5.31KlotVolume42.32Open41.69Pre Close22.20MTurnover1.23%Turnover Ratio32.04P/E (Static)90.88MShares61.6652wk High1.85P/B1.79BFloat Cap28.5052wk Low50.03Limit Up43.23MShs Float112.07Historical High33.35Limit Down2.85%Amplitude28.50Historical Low0.90Dividend TTM41.80Avg Price2.32KlotAsk2.17%Div YieldTTM100Lot Size2.55KlotBid
Bide Pharmatech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 1.65%265.74M | 8.72%1.21B | 8.30%826.96M | -2.42%550.57M | 6.24%261.43M | 27.66%1.11B | 25.98%763.56M | 54.80%564.23M | 55.07%246.08M | 43.23%871.65M |
| Refunds of taxes and levies | 4.06%13.19M | -17.66%51.24M | -24.68%37.42M | -23.55%27.49M | -26.83%12.67M | 69.47%62.23M | 138.74%49.68M | 188.47%35.96M | 146.31%17.32M | 25.33%36.72M |
| Cash received relating to other operating activities | -15.63%8.05M | -0.36%32.73M | -8.75%25.61M | -38.51%13.61M | -16.50%9.55M | 118.94%32.85M | 231.04%28.06M | 673.89%22.13M | 1,284.01%11.43M | 66.26%15M |
| Cash inflows from operating activities | 1.18%286.98M | 7.11%1.29B | 5.79%889.99M | -4.92%591.67M | 3.21%283.64M | 30.81%1.21B | 32.41%841.31M | 63.85%622.32M | 65.01%274.83M | 42.74%923.38M |
| Goods services cash paid | 36.21%221.04M | -16.48%796.02M | -25.19%547.52M | -34.63%339.28M | -31.85%162.27M | 44.21%953.15M | 52.28%731.86M | 93.32%519.04M | 32.71%238.12M | 27.38%660.95M |
| Staff behalf paid | -0.66%42M | -0.29%182.66M | 1.59%127.65M | 8.29%89.59M | 20.33%42.29M | 46.52%183.19M | 46.18%125.65M | 34.87%82.73M | 6.18%35.14M | 27.61%125.03M |
| All taxes paid | -63.36%5.88M | 9.70%71.01M | 3.63%53.29M | 18.82%37.36M | 133.80%16.05M | 4.07%64.73M | 67.51%51.43M | 119.77%31.44M | 36.85%6.87M | 47.97%62.2M |
| Cash paid relating to other operating activities | -26.24%10.96M | 33.60%85.7M | 10.37%60.98M | 4.17%35.77M | -8.02%14.86M | 41.52%64.15M | 31.11%55.25M | 20.96%34.34M | 14.88%16.16M | -14.30%45.33M |
| Adjustment items of operating cash outflws | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | 18.86%279.88M | -10.26%1.14B | -18.12%789.44M | -24.80%502M | -20.53%235.47M | 41.60%1.27B | 50.80%964.18M | 79.20%667.55M | 27.93%296.29M | 25.53%893.5M |
| Net cash flows from operating activities | -85.27%7.1M | 375.87%158.31M | 181.83%100.55M | 298.24%89.68M | 324.48%48.17M | -292.12%-57.39M | -2,948.00%-122.87M | -720.73%-45.24M | 67.02%-21.46M | 146.04%29.87M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --95M | 1,615.20%686.08M | --356M | --140M | ---- | --40M | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | --1.26M | 42,351.58%4.85M | --884.56K | --343.02K | ---- | --11.42K | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -0.27%317.02K | 137.59%2.2M | 933.76%2.33M | --1.82M | --317.88K | --925K | --225K | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | -96.91%1.15M | -89.08%1.04M | -84.95%1.04M | -69.95%1.04M | -65.75%37.1M | -52.59%9.56M | -65.60%6.93M | --3.47M | 149.58%108.34M |
| Cash inflows from investing activities | 6,993.48%96.58M | 789.63%694.28M | 3,582.27%360.25M | 1,965.21%143.21M | -60.80%1.36M | -27.97%78.04M | -51.47%9.78M | -65.92%6.93M | --3.47M | 85.01%108.34M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -60.21%918.13K | 44.64%88.35M | 190.62%74M | -49.40%5.9M | -67.24%2.31M | 59.01%61.08M | 113.26%25.46M | 55.95%11.65M | 3.86%7.04M | 31.53%38.41M |
| Cash paid to acquire investments | --837.38M | 1,810.00%764M | 1,490.00%636M | 910.00%404M | ---- | --40M | --40M | --40M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | -92.99%408.71K | ---- | ---- | ---- | -94.82%5.83M | -74.83%5.87M | -77.63%5.22M | -82.83%3.43M | --112.54M |
| Cash outflows from investing activities | 36,229.27%838.29M | 697.66%852.75M | 895.33%710M | 620.74%409.9M | -77.97%2.31M | -29.18%106.91M | 102.30%71.33M | 84.69%56.87M | -60.88%10.48M | 416.91%150.95M |
| Net cash flows from investing activities | -78,306.84%-741.72M | -449.02%-158.48M | -468.24%-349.75M | -434.04%-266.69M | 86.49%-945.98K | 32.26%-28.87M | -307.58%-61.55M | -378.14%-49.94M | 73.85%-7M | -245.15%-42.61M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 714.72%1.34B |
| Cash from borrowing | 482.38%231.5M | 41,998.47%97.35M | 1,984.54%112.17M | 24,455.47%74.73M | 20,364.70%39.75M | -97.59%231.23K | -48.54%5.38M | -96.85%304.35K | 252.53%194.24K | -53.64%9.61M |
| Cash received relating to other financing activities | ---- | 52.59%7.6M | ---- | ---- | ---- | --4.98M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 482.38%231.5M | 1,913.82%104.94M | 1,984.54%112.17M | 24,455.47%74.73M | 20,364.70%39.75M | -99.61%5.21M | -99.60%5.38M | -96.85%304.35K | 252.53%194.24K | 628.47%1.34B |
| Borrowing repayment | 3,837.13%9.1M | 613.76%68.01M | 465.35%54.01M | 290.65%37.32M | 68.61%231.23K | 13,136.84%9.53M | 13,171.09%9.55M | 13,171.09%9.55M | 90.52%137.14K | -99.81%71.98K |
| Dividend interest payment | --1.68M | -20.15%79.88M | -20.44%79.59M | -20.62%79.41M | ---- | 119,583.04%100.03M | 219,809.50%100.03M | 1,169,373.77%100.03M | --35.39K | -55.54%83.58K |
| Cash payments relating to other financing activities | -53.04%35.99M | 264.86%123.9M | 372.12%114.19M | 980.42%98.77M | 2,398.99%76.65M | -1.09%33.96M | 50.87%24.19M | 20.85%9.14M | -15.18%3.07M | 269.01%34.33M |
| Cash outflows from financing activities | -39.15%46.78M | 89.38%271.79M | 85.23%247.79M | 81.51%215.5M | 2,273.03%76.88M | 316.13%143.52M | 728.36%133.77M | 1,452.98%118.73M | -12.16%3.24M | -26.90%34.49M |
| Net cash flows from financing activities | 597.54%184.72M | -20.63%-166.84M | -5.63%-135.62M | -18.87%-140.76M | -1,119.11%-37.13M | -110.55%-138.31M | -109.66%-128.39M | -5,966.05%-118.42M | 16.18%-3.05M | 853.44%1.31B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 366.63%2.46M | 75.28%-1.44M | -217.18%-1.34M | -102.77%-101.75K | -455.57%-922.14K | -223.44%-5.83M | -77.91%1.14M | 129.02%3.67M | 77.70%-165.98K | 1,671.83%4.73M |
| Net increase in cash and cash equivalents | -6,068.17%-547.44M | 26.89%-168.45M | -23.90%-386.16M | -51.42%-317.87M | 128.96%9.17M | -117.69%-230.39M | -123.69%-311.67M | -1,423.47%-209.93M | 67.08%-31.67M | 1,181.70%1.3B |
| Add:Begin period cash and cash equivalents | -13.32%1.1B | -15.41%1.27B | -15.41%1.27B | -15.41%1.27B | -15.41%1.27B | 674.74%1.5B | 674.34%1.5B | 674.74%1.5B | 674.74%1.5B | 111.17%193.03M |
| End period cash equivalent | -56.90%549.18M | -13.32%1.1B | -25.75%878.91M | -26.32%947.2M | -12.95%1.27B | -15.41%1.27B | -21.54%1.18B | 617.18%1.29B | 1,411.97%1.46B | 674.74%1.5B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.